Pascal Deschatelets plans sale of 909 APLS shares

Pascal Deschatelets has filed a Form 144 notice relating to common stock of APLS, indicating an intent to sell 909 shares through Fidelity Brokerage Services on NASDAQ, with an approximate sale date of 01/20/2026.

Rhea-AI Filing Summary

Pascal Deschatelets has filed a Form 144 notice relating to common stock of APLS, indicating an intent to sell 909 shares through Fidelity Brokerage Services on NASDAQ, with an approximate sale date of 01/20/2026. These 909 shares were acquired on 01/16/2026 via restricted stock vesting from the issuer as compensation.

The notice also reports that during the past three months, Deschatelets sold 2,277 common shares for gross proceeds of 50520.25. The filing lists 126,525,218 shares of this class outstanding, providing context for the size of the planned and recent sales.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What does the APLS Form 144 filed by Pascal Deschatelets disclose?

It discloses that Pascal Deschatelets plans to sell 909 shares of APLS common stock on NASDAQ through Fidelity Brokerage Services LLC, with an approximate sale date of 01/20/2026.

How many APLS shares is Pascal Deschatelets planning to sell under this Form 144?

The Form 144 states that 909 common shares are planned to be sold, with an aggregate market value of 17991.75 at the time of the notice.

How and when did Pascal Deschatelets acquire the APLS shares to be sold?

The filing shows that the 909 shares were acquired on 01/16/2026 through restricted stock vesting from the issuer, with the nature of payment listed as compensation.

What APLS share sales has Pascal Deschatelets reported in the past three months?

Over the past three months, Deschatelets reported selling 2,277 common shares on 01/13/2026, generating gross proceeds of 50520.25.

How many APLS common shares are reported as outstanding in this Form 144?

The securities information table lists 126,525,218 common shares as the number of shares outstanding for this class of APLS stock.

What type of transaction is this APLS Form 144 related to under Rule 144?

The Form 144 is a notice of proposed sale under Rule 144, covering the planned sale of restricted common shares acquired via restricted stock vesting and reported together with other recent sales by the same person.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 01/20/2026 - 03:26 PM Learn about SEC filing dates

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK	0001657720
Filer CCC	XXXXXXXX
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer	Apellis Pharmaceuticals, Inc.
SEC File Number	001-38276
Address of Issuer	100 FIFTH AVENUE WALTHAM MASSACHUSETTS 02451
Phone	617-977-5700
Name of Person for Whose Account the Securities are To Be Sold	Deschatelets Pascal
See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.
Relationship to Issuer	Officer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common	Fidelity Brokerage Services LLC 900 Salem Street Smithfield RI 02917	909	17991.75	126525218	01/20/2026	NASDAQ

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common	01/16/2026	Restricted Stock Vesting	Issuer			909	01/16/2026	Compensation

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Name and Address of Seller	Title of Securities Sold	Date of Sale	Amount of Securities Sold	Gross Proceeds
Pascal Deschatelets 100 Fifth Avenue Waltham MA 02451	Common	01/13/2026	2277	50520.25

144: Remarks and Signature

Remarks	Sale includes an amount necessary to cover a tax obligation resulting from the settlement of a vested equity award distribution.
Date of Notice	01/20/2026
ATTENTION:
The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.
Signature	/s/ Joshua Schmitt, as a duly authorized representative of Fidelity Brokerage Services LLC, as attorney-in-fact for Pascal Deschatelets.
ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)